Taylor & Francis Journals: Welcome 
Contact Us Careers Members of the Group
Taylor & Francis Journals: Welcome 
Search
Journal Listings
Alphabetical Listing
Journals by Subject
New Journals
Author Resources
Author Services
Authors' Newsletter
Copyright & Author Rights
Instructions for Authors
Journals Resources
Advertising
Catalogues
Customer Services
Developing World Initiatives
Email Contents Alerting
eUpdates
Library Recommendation Form
Online Information
Permissions
Press Releases
Price Lists
Publish with Us
Reprints
Special Issues
Special Offers
Subscription Information
Related Websites
Arenas
LibSite
Society Publishing
Routledge Books
Taylor & Francis Books
Garland Science

Journal Details

Printer Friendly Page
Journal of Psychoactive Drugs

Journal of Psychoactive Drugs


New to Routledge in 2011
Increasing to 5 issues in 2012
Published By: Routledge
Volume Number: 43
Frequency: 4 issues per year
Print ISSN: 0279-1072
 

Aims & Scope

An authoritative peer-reviewed periodical containing timely information of a multidisciplinary nature for clinicians and other professionals in the drug abuse field; Journal of Psychoactive Drugs consistently addresses complex issues such as the disease concept of addiction, drugs and mental health, use and abuse of hallucinogens, ethnographic drug research, drug dependence and the family and more!

Throughout its forty-four year history, the Journal of Psychoactive Drugs has been on the leading edge of developments in the study of substance use and abuse from a multidisciplinary perspective.

It was the first journal established in the United States to focus on psychoactive drug abuse, and continues to introduce groundbreaking work in topics such as drug use and criminality, therapeutic communities, dual diagnosis, psychotherapy/counseling, methadone maintenance treatment, and culturally relevant substance abuse treatment. 

The Journal of Psychoactive Drugs publishes research, case reports and other studies dealing with the experimental and policy issues of drug use as well as the treatment of drug abuse.
 

2010 Impact Factor: 0.72
© 2011 Thomson Reuters, Journal Citation Reports®

top top
Copyright © 2012 Taylor & Francis Group, an informa business   Privacy Policy   Terms and Conditions